Intrathecal Morphine is one of 273 small molecule programs targeting Metastasis. It is currently in Phase 3.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
83 competitors in Cesarean Section
Intrathecal Morphine
Fentanyl-Morphine
Ondansetron, Dexamethasone
Acetaminophen/ibuprofen
Sebacoyl Dinalbuphine Ester
Morphine - .
Dynastat
Proamatine
Duragesic
Versed
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Sources
Details